{"id":"W2543677770","doi":"10.3747/co.23.3139","title":"The Cost-Effectiveness of Bevacizumab for the Treatment of Advanced Ovarian Cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Current Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Roche (Canada)","funders":"","keywords":"Medicine; Bevacizumab; Oncology; Ovarian cancer; Internal medicine; Quality-adjusted life year; Incremental cost-effectiveness ratio; Cost effectiveness; Population; Randomized controlled trial; Progression-free survival; Cost-effectiveness analysis; Chemotherapy; Quality of life (healthcare); Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002938184,0.0005391044,0.0006814935,0.0009858561,0.0007566895,0.001481775,0.001243415,0.0006306827,0.002299049],"category_scores_gemma":[0.011983,0.0003137262,0.00149457,0.001947052,0.000600725,0.0004596313,0.0007878082,0.0009985747,0.00007555848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1024192,"about_ca_system_score_gemma":0.0866323,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9789089,"about_ca_topic_score_gemma":0.9774013,"domain_scores_codex":[0.9978823,0.0009093946,0.00008129732,0.0001417698,0.0005928723,0.0003923512],"domain_scores_gemma":[0.9967635,0.001412217,0.0004469898,0.00007541464,0.0009370492,0.000364781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.01435441,0.0006054169,0.1186993,0.003890969,0.005006684,0.0007739987,0.000388648,0.6660741,0.001282779,0.01836326,0.02279597,0.1477644],"study_design_scores_gemma":[0.008997054,0.002943034,0.2464713,0.002674908,0.008085568,0.0007182953,0.001015202,0.6757058,0.002059,0.01347329,0.03749086,0.0003656169],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8992379,0.03328187,0.004436733,0.01177709,0.0001811407,0.001429817,0.02229103,0.0001295265,0.02723495],"genre_scores_gemma":[0.9913757,0.003806232,0.001384989,0.0003450006,0.00001657384,0.0001166694,0.001977437,0.00001094405,0.0009664544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1024192,"threshold_uncertainty_score":0.7431066,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08156632930246596,"score_gpt":0.4139633159310752,"score_spread":0.3323969866286092,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}